Patent Yard Sign in
Canadian application, no grantCanada

Ex-vivo test kit for testing the effectiveness of reversers of multidrug resistance

CA 2331432 A1 · Owner: Kott, Miriam Viviana · Inventors: Stein, Wilfred Donald; Kott, Miriam Viviana

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention provides an ex-vivo test kit for testing the effectiveness of reversers of multidrug resistance in the blood serum or plasma of a patient, containing said reversers said kit comprising a plurality of cell membranes from, drug-resistant cells, the cell membranes containing proteins which pump drugs and the membranes being respectively attached to a plurality of support surfaces and a dye which provides a light signal which dye is pumped by the, proteins contained in the membranes out of the membranes and into membrane sacs that are attached to the support surfaces.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed January 18, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended January 18, 2021.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 18, 2023.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJanuary 18, 2001
GrantedNo grant recorded
Term endedJanuary 18, 2021
Patent numberCA 2331432 A1
Classification (IPC)C12Q1/00 +2 more

Timeline

Timeline From CIPO dates

2002200420062008201020122014201620182020Application filedJan 18, 2001Term endedJan 18, 2021

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.